Abstract
In recent years, with the emergence of multidrug-resistant and extremely drug-resistant organisms, there has been an increase in the use of polymyxins, which in some situations are the last therapeutic option. Resistance to polymyxins has been described and the most common mechanism found in isolates resistant to polymyxins are mutations in chromosomal genes (for example, pmrA, pmrB, mgrB…